Athersys to Host Second Quarter Financial Results Call

Date : 07/08/2019 @ 3:00PM
Source : GlobeNewswire Inc.
Stock : Athersys Inc (ATHX)
Quote : 1.29  0.01 (0.78%) @ 9:39PM
After Hours
Last Trade
Last $ 1.27 ▼ -0.02 (-1.55%)

Athersys to Host Second Quarter Financial Results Call

Athersys (NASDAQ:ATHX)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Athersys Charts.

Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Members of the management team will host the call as follows:

 Date August 7, 2019
 Time 4:30 p.m. (Eastern Time)
 Telephone access: US and Canada (877) 396-3286
 Telephone access: International (647) 689-5528
 Encore Passcode (needed for the replay only) 5087881
 Live webcast under Investors section

We encourage shareholders to listen using the webcast link and to use the phone line if you intend to ask a question.  A replay will be available on the webcast at under the investors section approximately two hours after the call has ended.  Shareholders may also call in for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on August 14, 2019 by dialing (800) 585-8367 or (416) 621-4642 and entering Encore passcode 5087881.

About Athersys

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.  More information is available at


William (B.J.) Lehmann, J.D.                          President and Chief Operating Officer                                              Tel: (216) 431-9900                                   

Karen Hunady Director of Corporate Communications and Investor RelationsTel: (216)

David Schull                 Russo Partners, LLCTel: (212) 845-4271 or (858)

Latest ATHX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.